A review of quetiapine in combination with antidepressant therapy in patients with depression

Ella J. Daly, Madhukar H. Trivedi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Atypical antipsychotics are increasingly used in the treatment of a broad spectrum of psychiatric disorders. There is evidence that in addition to treating the positive and negative symptoms of schizophrenia, as well as mania in bipolar disorder, these agents may have a potential role to play in the treatment of depressive disorders. In the following article we review the literature regarding the role of atypical antipsychotics, and specifically, quetiapine, in the treatment of major depressive disorder. Materials and methods: In March 2007 the authors performed a Medline search (English-language) using the keywords quetiapine and depression, revealing a total of 47 articles published. We also looked for cross-references in the published articles, obtained data-on-file from AstraZeneca Pharmaceutical L.P., and included abstracts presented at conferences and recent meetings. Results: From our review we found that there is increasing literature supporting the efficacy of add-on quetiapine in the treatment of major depressive disorder. Conclusion: There is a need, however, for further well-designed, adequately powered, randomized, controlled trials to confirm this finding, specifically in unipolar depression.

Original languageEnglish (US)
Pages (from-to)855-867
Number of pages13
JournalNeuropsychiatric Disease and Treatment
Volume3
Issue number6
StatePublished - 2007

Fingerprint

Antidepressive Agents
Depression
Major Depressive Disorder
Depressive Disorder
Bipolar Disorder
Antipsychotic Agents
Information Storage and Retrieval
Therapeutics
Psychiatry
Schizophrenia
Language
Randomized Controlled Trials
Quetiapine Fumarate
Pharmaceutical Preparations

Keywords

  • Adjunctive treatment
  • Atypical antipsychotics
  • Depression
  • Quetiapine

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

A review of quetiapine in combination with antidepressant therapy in patients with depression. / Daly, Ella J.; Trivedi, Madhukar H.

In: Neuropsychiatric Disease and Treatment, Vol. 3, No. 6, 2007, p. 855-867.

Research output: Contribution to journalArticle

@article{d3e575f5d44644d5a3e0d3e03b33a63c,
title = "A review of quetiapine in combination with antidepressant therapy in patients with depression",
abstract = "Background: Atypical antipsychotics are increasingly used in the treatment of a broad spectrum of psychiatric disorders. There is evidence that in addition to treating the positive and negative symptoms of schizophrenia, as well as mania in bipolar disorder, these agents may have a potential role to play in the treatment of depressive disorders. In the following article we review the literature regarding the role of atypical antipsychotics, and specifically, quetiapine, in the treatment of major depressive disorder. Materials and methods: In March 2007 the authors performed a Medline search (English-language) using the keywords quetiapine and depression, revealing a total of 47 articles published. We also looked for cross-references in the published articles, obtained data-on-file from AstraZeneca Pharmaceutical L.P., and included abstracts presented at conferences and recent meetings. Results: From our review we found that there is increasing literature supporting the efficacy of add-on quetiapine in the treatment of major depressive disorder. Conclusion: There is a need, however, for further well-designed, adequately powered, randomized, controlled trials to confirm this finding, specifically in unipolar depression.",
keywords = "Adjunctive treatment, Atypical antipsychotics, Depression, Quetiapine",
author = "Daly, {Ella J.} and Trivedi, {Madhukar H.}",
year = "2007",
language = "English (US)",
volume = "3",
pages = "855--867",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",
number = "6",

}

TY - JOUR

T1 - A review of quetiapine in combination with antidepressant therapy in patients with depression

AU - Daly, Ella J.

AU - Trivedi, Madhukar H.

PY - 2007

Y1 - 2007

N2 - Background: Atypical antipsychotics are increasingly used in the treatment of a broad spectrum of psychiatric disorders. There is evidence that in addition to treating the positive and negative symptoms of schizophrenia, as well as mania in bipolar disorder, these agents may have a potential role to play in the treatment of depressive disorders. In the following article we review the literature regarding the role of atypical antipsychotics, and specifically, quetiapine, in the treatment of major depressive disorder. Materials and methods: In March 2007 the authors performed a Medline search (English-language) using the keywords quetiapine and depression, revealing a total of 47 articles published. We also looked for cross-references in the published articles, obtained data-on-file from AstraZeneca Pharmaceutical L.P., and included abstracts presented at conferences and recent meetings. Results: From our review we found that there is increasing literature supporting the efficacy of add-on quetiapine in the treatment of major depressive disorder. Conclusion: There is a need, however, for further well-designed, adequately powered, randomized, controlled trials to confirm this finding, specifically in unipolar depression.

AB - Background: Atypical antipsychotics are increasingly used in the treatment of a broad spectrum of psychiatric disorders. There is evidence that in addition to treating the positive and negative symptoms of schizophrenia, as well as mania in bipolar disorder, these agents may have a potential role to play in the treatment of depressive disorders. In the following article we review the literature regarding the role of atypical antipsychotics, and specifically, quetiapine, in the treatment of major depressive disorder. Materials and methods: In March 2007 the authors performed a Medline search (English-language) using the keywords quetiapine and depression, revealing a total of 47 articles published. We also looked for cross-references in the published articles, obtained data-on-file from AstraZeneca Pharmaceutical L.P., and included abstracts presented at conferences and recent meetings. Results: From our review we found that there is increasing literature supporting the efficacy of add-on quetiapine in the treatment of major depressive disorder. Conclusion: There is a need, however, for further well-designed, adequately powered, randomized, controlled trials to confirm this finding, specifically in unipolar depression.

KW - Adjunctive treatment

KW - Atypical antipsychotics

KW - Depression

KW - Quetiapine

UR - http://www.scopus.com/inward/record.url?scp=38149003621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149003621&partnerID=8YFLogxK

M3 - Article

C2 - 19300621

AN - SCOPUS:38149003621

VL - 3

SP - 855

EP - 867

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

IS - 6

ER -